1997-6933

Clinical oncohematology

Practical Medicine Publishing House

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 611 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact611 DOIs
2

Deposit reference lists for 21 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact21 DOIs
3

Add abstracts to 7 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact7 DOIs

DOIs for this ISSN

Showing the top 5 of 698 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Iron Metabolism in Normal and Pathological Conditions (10.21320/2500-2139-2015-8-4-355-361)
ORCID
36.56 28
2 National Clinical Guidelines on Diagnosis and Treatment of P… (10.21320/2500-2139-2021-14-2-262-298)
ORCID
34.51 23
3 Clinical Recommendations for the Diagnosis and Treatment of… (10.21320/2500-2139-2017-10-3-294-316)
ORCID
33.56 21
4 Biology of Myeloproliferative Malignancies (10.21320/2500-2139-2016-9-3-314-325)
ORCID
30.10 15
5 Chronic Myeloid Leukemia Patient Registry in the Russian Fed… (10.21320/2500-2139-2017-10-3-390-401)
ORCID
30.10 15
6 Paroxysmal Nocturnal Hemoglobinuria: Current View on a Rare… (10.21320/2500-2139-2019-12-1-4-20)
References ORCID
30.10 3
7 Protocol ALL-IC BFM 2002: Outcomes of Pediatric Acute Lympho… (10.21320/2500-2139-2022-15-2-119-129)
ORCID
30.10 15
8 Multiple myeloma (pathogenesis, clinical features, diagnosis… (10.21320/2500-2139-2013-6-3-237-257)
ORCID
27.85 12
9 Pathogenetic Characteristics of Anemia in Patients with Soli… (10.21320/2500-2139-2017-10-4-208-217)
ORCID
26.98 11
10 Immune Checkpoint Inhibitors in the Treatment of Lymphomas (10.21320/2500-2139-2018-11-4-303-312)
ORCID
26.98 11
11 Clinical Manifestation and Errors in the Diagnosis of Classi… (10.21320/2500-2139-2017-10-3-333-341)
ORCID
26.03 10
12 Prognostic Models in Medicine (10.21320/2500-2139-2023-16-1-27-36)
ORCID
26.03 10
13 Non-Hodgkin’s Lymphomas in Children: 25-Year Clinical Experi… (10.21320/2500-2139-2016-9-4-420-437)
ORCID
25.00 9
14 Anemia of Chronic Disease: Key Mechanisms of Pathogenesis in… (10.21320/2500-2139-2019-12-3-344-349)
ORCID
25.00 9
15 Artificial Intelligence in Hematology (10.21320/2500-2139-2022-15-1-16-27)
ORCID
25.00 9
16 First-Line Therapy for Patients with Advanced Hodgkin’s Lymp… (10.21320/2500-2139-2017-10-4-443-452)
ORCID
23.86 8
17 Correction of Anemia and Evaluation of Efficacy of Red Blood… (10.21320/2500-2139-2018-11-3-265-272)
ORCID
23.86 8
18 Epidemiology of Multiple Myeloma in Novosibirsk (Siberian Fe… (10.21320/2500-2139-2019-12-1-86-94)
ORCID
23.86 8
19 Analysis Results of the Regional Registry of Patients with D… (10.21320/2500-2139-2019-12-2-154-164)
ORCID
23.86 8
20 Rhythm and Conduction Disorders in Patients Receiving Ibruti… (10.21320/2500-2139-2019-12-2-220-230)
ORCID
23.86 8
21 Multiple Myeloma (10.21320/2500-2139-2020-13-1-1-24)
References ORCID
23.86 2
22 Cardio-oncology and Oncohematology: Examination Algorithms,… (10.21320/2500-2139-2021-14-2-239-261)
ORCID
23.86 8
23 Second Generation Tyrosine Kinase Inhibitors and Their Toxic… (10.21320/2500-2139-2015-8-3-302-308)
ORCID
22.58 7
24 Evaluation of Minimal Residual Disease in B-Lineage Acute Ly… (10.21320/2500-2139-2017-10-2-158-168)
ORCID
22.58 7
25 Development and Validation Results of the Russian MPN10 Form… (10.21320/2500-2139-2020-13-2-176-184)
ORCID
22.58 7
26 Evolution of concepts for diagnosis and treatment of Burkitt… (10.21320/2500-2139-2014-7-1-46-56)
ORCID
21.13 6
27 Molecular Monitoring of WT1 Gene Expression Degree in Acute… (10.21320/2500-2139-2015-8-3-309-320)
ORCID
21.13 6
28 Acute Leukemias: Immunophenotypic Differences between Blast… (10.21320/2500-2139-2016-9-3-302-313)
ORCID
21.13 6
29 Anemias in Oncology: Potential of Maintenance Therapy (10.21320/2500-2139-2016-9-3-326-335)
ORCID
21.13 6
30 Certain Aspects of Autologous Hematopoietic Stem Cell Transp… (10.21320/2500-2139-2017-10-1-7-12)
ORCID
21.13 6
31 Thrombophilia and Pregnancy (10.21320/2500-2139-2017-10-3-409-422)
ORCID
21.13 6
32 Checkpoint Inhibitors and Classical Hodgkin’s Lymphoma: Effi… (10.21320/2500-2139-2021-14-1-53-62)
ORCID
21.13 6
33 High-risk chronic lymphocytic leukemia: history, definition,… (10.21320/2500-2139-2013-6-1-60-68)
ORCID
19.45 5
34 Biology of Hematopoietic Stem Cell Niche (10.21320/2500-2139-2014-7-4-501-510)
ORCID
19.45 5
35 MicroRNA: Small Molecules of Great Significance (10.21320/2500-2139-2015-8-1-1-12)
ORCID
19.45 5
36 New Aspects of Pathophysiology and Pathomorphology of Renal… (10.21320/2500-2139-2015-8-4-390-396)
ORCID
19.45 5
37 Polycythemia Vera: Literature Review and Own Data (10.21320/2500-2139-2015-8-4-397-412)
ORCID
19.45 5
38 Chronic Myeloid Leukemia: Long-Term Experience of Target The… (10.21320/2500-2139-2016-9-1-54-60)
ORCID
19.45 5
39 WT1 Gene Overexpression in Oncohematological Disorders: Theo… (10.21320/2500-2139-2016-9-3-257-264)
ORCID
19.45 5
40 Clinical and Hematological Characteristics of Patients with… (10.21320/2500-2139-2017-10-1-65-74)
ORCID
19.45 5
41 V(D)J Recombination Excision Circles of B- and T-cells as Pr… (10.21320/2500-2139-2017-10-2-131-140)
ORCID
19.45 5
42 Manufacturing of CD19 Specific CAR T-Cells and Evaluation of… (10.21320/2500-2139-2018-11-1-1-9)
ORCID
19.45 5
43 Clinical Significance of the PRAME Gene Expression in Oncohe… (10.21320/2500-2139-2018-11-1-26-33)
ORCID
19.45 5
44 Hematopoietic Stem Cell Collection in Multiple Myeloma Patie… (10.21320/2500-2139-2018-11-2-192-197)
ORCID
19.45 5
45 Expression of Adhesion Molecule CD56 in Tumor Plasma Cells i… (10.21320/2500-2139-2019-12-4-377-384)
ORCID
19.45 5
46 Current View on Diagnosis and Treatment of Classical Ph-Nega… (10.21320/2500-2139-2021-14-1-129-137)
ORCID
19.45 5
47 Current Quality-of-Life Aspects in Patients with Classical P… (10.21320/2500-2139-2022-15-2-176-197)
ORCID
19.45 5
48 International prognostic score in advanced Hodgkin’s lymphom… (10.21320/2500-2139-2013-6-3-294-302)
ORCID
17.47 4
49 Current therapies for AL amyloidosis: literature review and… (10.21320/2500-2139-2013-6-3-303-311)
ORCID
17.47 4
50 Hematopoietic stem cell transplantation in AML patients with… (10.21320/2500-2139-2013-6-4-439-444)
ORCID
17.47 4